CIK 0001651308
- Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981209416
- Phone
- +41 616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- 4 Grant or award Chief Financial Officer acquired 63,674 shares (grant or award)
- 4 Grant or award Global Head of R&D acquired 86,359 shares (grant or award)
- 4 Grant or award President and COO acquired 123,370 shares (grant or award)
- 4 Planned sale Director sold 41,760 shares at an average $262.82 ($10,975,316)
- 4 Grant or award Chief Executive Officer acquired 185,055 shares (grant or award)
- 4 Other disposition Director disposed of 29,614 shares (other)
- 4 Open-market sale SVP, General Counsel sold 700 shares at an average $256.11 ($179,280)
- 4 Open-market sale Global Head of R&D sold 1,402 shares at an average $252.39 ($353,853)
- 4 Open-market sale President and COO sold 1,934 shares at an average $253.15 ($489,591)
- 4 Open-market sale Chief Executive Officer sold 5,127 shares at an average $252.77 ($1,295,946)
- 4 Grant or award Director acquired 10,985 shares (grant or award)
- 4 Grant or award Director acquired 10,985 shares (grant or award)
- 4 Grant or award Director acquired 10,985 shares (grant or award)
- 4 Grant or award Director acquired 10,985 shares (grant or award)
- 4 Grant or award Director acquired 10,985 shares (grant or award)
- 4 Grant or award Director acquired 10,985 shares (grant or award)
- 4 Grant or award Director acquired 10,985 shares (grant or award)
- 4 Grant or award Director acquired 43,940 shares (grant or award)
- 4 Planned sale Director sold 41,760 shares at an average $223.50 ($9,333,272)
- 4 Shares withheld for taxes Chief Executive Officer gave up 1,990,603 shares (to pay taxes)
Page 6 of 29 · 580 filings